Midgard Science

Labs / Assays & in vitro testing

Axcelead

Kanagawa, Japan · axcelead-us.com

On your own

Free. Their own form.

Contact Axcelead directly

Through Midgard

Midgard sends your request to the lab and keeps the order's messages, papers and payments in one place. Free to ask. 1% platform fee if you keep the order on Midgard.

Request a quote through Midgard

Axcelead Drug Discovery Partners, Inc. provides drug discovery and development services for biotechnology and pharmaceutical partners. It was formed in 2017 as a Takeda spin-out and is based in Fujisawa, Kanagawa, Japan. Its work spans preclinical discovery programs in small molecules, cell therapy, and immune-oncology.

Their website has a general contact form; we send your quote request through it.

What they offer

  • Integrated Drug Discovery

    Supports drug discovery programs across target identification through candidate selection and IND enabling work.

  • Axcelead Booster

    Provides an integrated drug discovery platform for partner programs.

  • Target Identification / Validation

    Supports identification of novel drug targets using human data-driven transcriptomics and proteomics, and validates targets in human samples and animal disease models.

  • Hit Identification / Characterization

    Designs HTS strategies from assay development through hit characterization using curated library sets and prior HTS experience.

  • Lead Generation / Optimization

    Supports lead generation and optimization within its drug discovery platform.

  • Candidate Selection

    Advances programs toward candidate selection in the discovery workflow.

  • IND Enabling

    Supports preclinical activities needed to advance candidates toward human clinical trials.

  • Omics

    Uses omics technologies to link genes, proteins, and metabolites for biological insight.

  • Bioinformatics

    Converts omics and genomics data into actionable insights for drug discovery.

  • Targeted Protein Degradation

    Provides TPD drug discovery capabilities at the preclinical stage.

  • RNA-Targeted Small Molecules

    Provides integrated RNA-targeted small molecule drug discovery capabilities at the preclinical stage.

  • In Vitro/In Vivo Pharmacology

    Offers pharmacology support as part of its technology platform.

  • Chemistry

    Provides chemistry support within the drug discovery platform.

  • Genetically Modified Animal

    Uses genetically modified animal models as a technology platform.

What they work on

Modalities
Small molecule, Peptide, Oligonucleotide, Cell therapy
Species and models
human samples, animal disease models, genetically modified animal
Assays and studies
transcriptomics, proteomics, high-throughput screening, assay development, hit characterization
Scale and capacity
1.5 million compounds, 700+ HTS experiences, About 240 employees
Therapeutic areas
Oncology, Immunology, Neuroscience, Cardiovascular / Metabolic Disease
Sites
Fujisawa, Kanagawa, Japan
Team
About 240
Serves
Japan, around the world
Founded
2017

Similar labs. Aurigene Pharmaceutical Services, MedChem Partners, Sai Life, CDI Labs

Found in a contract services directory. Listing built from axcelead-us.com. Work here? Claim this listing.

Axcelead · Midgard Science